The largest database of trusted experimental protocols

6 protocols using c peptide elisa

1

Streptozotocin-Induced Diabetes and Islet Transplantation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The recipient NHP received Streptozotocin (STZ) I.V. at dose of 75 mg/kg (Zanosar, Teva Parenteral Medicines, Irvine, CA). Thereafter, blood glucose (BG) levels were monitored twice daily via tail pricking (Accu-check Aviva, Roche Diagnostics, Indianapolis, IN). Diabetes was defined as three consecutive fasting BG readings >300 mg/dL and c-peptide levels < 0.5 ng/mL (Mercodia C-peptide ELISA, Mercodia AB, Uppsala, Sweden). The post-STZ period is defined as from the time of STZ injection until the day of islet transplantation. Post-transplant graft rejection was defined as three days of consecutive fasting BG >180 mg/dL or non-fasting BG >250 mg/dL. Insulin (Humulin R, Lilly, Indianapolis, IN) and Lantus (Lilly, Indianapolis, IN) was administered by sliding scale to achieve BG <250 mg/dL pre-transplant or after graft rejection was defined.
+ Open protocol
+ Expand
2

Plasma Biomarker Detection Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma was separated from blood samples by centrifugation, aliquoted and stored at −80 °C.
Plasma level of irisin was detected using the irisin recombinant enzyme immunoassay kit (Phoenix Pharmaceuticals, Inc., Burlingame, CA, USA. Cat #EK-067-29). For the assay, kit instructions were followed: briefly, plasma samples were thawed on ice and centrifuged for 5 min at 10,000× g at 4 °C to remove any remaining cells or platelets. Then samples were diluted 40× with the 1× assay buffer (provided in the kit). The intra-assay coefficient for this ELISA assay was 1.0–7.0%, while the inter-assay coefficient was < 20%.
Plasma level of ANGPTL3 was detected with the Quantikine Human Angiopoietin-like 3 (ANGPTL3) ELISA (R&D systems, Minneapolis, MN, USA. Cat# DANL30) according to the manufacturer protocol.
C-peptide plasma level was detected with Mercodia C-peptide ELISA (Mercodia AB, Sylveniusgatan, Sweden, Cat# 10-1136-01) according to the manufacturer protocol.
+ Open protocol
+ Expand
3

Streptozotocin-Induced Diabetes Model in NHPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The recipient NHPs received streptozotocin (STZ) I.V. at the dose of 75 mg/kg (Zanosar, Teva Parenteral Medicines, Irvine, CA). Thereafter, blood glucose (BG) levels were monitored twice daily via tail pricking (Accu-check Aviva, Roche Diagnostics, Indianapolis, IN). Diabetes was defined as three consecutive fasting BG readings >300 mg/dL and C-peptide levels <0.5 ng/mL (Mercodia C-peptide ELISA, Mercodia AB, Uppsala, Sweden). The post-STZ period is defined as from the time of STZ injection until the day of islet transplantation. Posttransplant graft rejection was defined as three days of consecutive fasting BG > 180 mg/dL or non-fasting BG > 250 mg/dL. Insulin (Humulin R and Lantus, Lilly, Indianapolis, IN) was administered by sliding scale to achieve BG < 250 mg/dL pretransplant or after graft rejection was defined.
+ Open protocol
+ Expand
4

Ultrasensitive C-peptide ELISA in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human C-peptide levels were measured in mouse serum using ultrasensitive C-peptide ELISA (Mercodia, Uppsala, Sweden) according to the manufacturer’s protocol. Data are represented as average values (±SD) from two donors with 3–5 mice each donor.
+ Open protocol
+ Expand
5

Serum Insulin, C-Peptide, and Glucagon Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
All measurements were carried out on animals of 2–6 months of age. Mice were fasted 18 hours before blood and serum collection. Blood samples were collected from the tail vein, and glucose concentration was determined using a Glucotrend 2 kit (Roche). Serum was obtained after clotting, and separation was obtained by centrifugation. Quantification was performed with a solid-phase, two-site ELISA immunoassay specific for mouse insulin (Ultrasensitive mouse insulin ELISA, Mercodia, Cat No 10-1247-01), c-peptide (c-peptide ELISA, Mercodia, Cat No 10-1172-01) and glucagon (Glucagon ELISA, Mercodia Cat No 10-1271-01). Assays for each serum were performed in duplicate.
+ Open protocol
+ Expand
6

Measurement of Intracellular C-peptide in Regenerative Beta Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For measurement of intracellular of C-peptide content, we harvested two-week old rGBC by rinsing with prewarmed PBS 3 times and lysing in 1X cell lysis buffer (Cell Signaling Technology, Danvers, MA, USA) with a complete mini-protease inhibitor cocktail (Roche, Mannheim, Germany). The cells were scraped off the dish, sonicated, and centrifuged at 14,000g at 4°C, saving the supernatant for C-peptide ELISA (Mercodia, Uppsala, Sweden). The C-peptide secretion assay was done as described previously [17 (link)]. Specifically, 2-week old rGBC in 12-well plates were incubated in fresh prewarmed day 14 reprogramming medium (MM3) for 2 hours at 37°C, then followed by rinsing three times with plain Krebs-Ringer bicarbonate buffer (KRBB) 20 minutes each at 37°C. Subsequently, rGBC were incubated with 150 μL KRBB with or without 1mM or 2.8 mM glucose for 2 hours in a humidified 37°C incubator. Supernatants were collected, centrifuged to remove cell debris, and stored at -80°C. Into the same wells, we added 150 μL KRBB with 25 mM glucose and incubated for 2 additional hours and harvested the supernatants. Total protein contents were measured using a BCA protein assay kit (Pierce Biotechnology, Rockford, IL, USA). Glucose-stimulated C-peptide was measured using Ultrasensitive Human C-peptide ELISA kit (Mercodia, Uppsala, Sweden).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!